Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.

Cihan AtilaOdile GaislDeborah R VogtLaura WerlenGabor SzinnaiMirjam Christ-Crain

Published in: European journal of endocrinology (2022)

Glucagon stimulates the neurohypophysis, and glucagon-stimulated copeptin has the potential for a safe, novel, and precise test in the differential diagnosis of diabetes insipidus.

Keyphrases

type diabetes
double blind
cardiovascular disease
glycemic control
placebo controlled
metabolic syndrome
risk assessment
climate change